Skip to main content

From biotech startups to big pharma, we follow the science.

Our team speaks the same language as our clients do, and helps them navigate the product life cycle – from M&A to patent and product liability proceedings. Working together, at every stage, to bring new products to market and protect your assets.
Subscribe Fasken


The lawyers at Fasken work with clients throughout the product life cycle and at every level of involvement. We have the scientific backgrounds and respected experience to provide strategic advice in almost any situation where it is needed.

By collaborating with colleagues who know the specific regulatory, marketing, intellectual property, competition, tax, litigation and business law matters unique to life sciences, we create multi-disciplinary solutions that protect client interests as their products move from conception to consumer or clinical use.


Our clients range from start-up biotech companies to the biggest pharmaceutical. We also work with clients from the  medical devices, natural health product (NHP), cosmetic, cannabis, veterinary, and human tissues. We help all life sciences industry stakeholders, including manufacturers, distributors, hospitals, pharmacies, retailers, academic and financial institutions and third-party research organizations.


Your team at Fasken includes lawyers with advance degrees in pharmaceutical sciences, clinical pharmacology, toxicology and genetics with a strong network of life sciences experts in 47 countries across the globe. We are committed to leadership in life sciences law; we write the leading guide to legal and regulatory regimes governing the manufacture and sale of drugs, medical devices and cosmetics in Canada and give frequent presentations to client organizations and associations. We’ve also been honored by respected organizations including Chambers, LMG Life Sciences, Who’s Who Legal, among others for innovative work year after year.


Read our publications, browse some of our recent life sciences work we’ve assisted with or contact any of our lawyers to learn more. 

Areas of Expertise



Client Work

  • ATB Capital Markets Inc. leads private placement of units of The Cannabist Company Holdings Inc.,
  • A.G.P./Alliance Global Partners and ATB Capital Markets Inc. co-lead private placement of units of Canopy Growth,
  • Sygnature Discovery acquires NuChem Sciences,
  • Filament Health announces non-brokered private placement unit offering of C$2.5 million,
  • Debiopharm Innovation Fund and Benchstrength co-lead a C$7.9 million seed funding round for Altis Labs Inc.,
  • Solabia Group acquires majority stake in Applechem,
  • Algernon Pharmaceuticals Inc. completes C$1.1 million rights offering,
  • Beacon Securities Limited and Canaccord Genuity Corp. co-lead underwriting syndicate in approximate C$42.5 million bought deal public offering and concurrent private placement for Quipt Home Medical Corp.,
  • LifeSpeak Inc. enters into C$15 million convertible loan with Beedie Investments Ltd.,


Fasken Institute



    Receive email updates from our team